MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
201
Unique beneficiaries
—
Total services
296
Distinct HCPCS
4
Medicare payment
$22K
PRESCRIBING · PART D · 2024
Total Rx claims
775
Beneficiaries
—
Total drug cost
$702K
Distinct drugs
23
Brand share
29.2%
Top prescribed drugs
Hydroxychloroquine Sulfate115 claims
Methotrexate Sodium106 claims
Meloxicam102 claims
Prednisone85 claims
Leflunomide54 claims
QUALITY · MIPS · 2024
Final MIPS score
32.9
Quality
10.0
Cost
70.3
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-5.06%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$3K
Payment records
128
By payment type
Food and Beverage$3K
Top paying entities
Food and Beverage$3K
REFERRAL NETWORK
Where Timothy Lazarek's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Unilab Corporation Clinical Laboratory · West Hills, CA | 32 | 73 |
| Soumya Rao Rheumatology · Poway, CA | 12 | 22 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE